Most of the difficulty in this category is chemical rather than commercial. Pure L-ascorbic acid is the best-evidenced brightening active available to a cosmetic formulator, and it is also one of the least stable materials in the cabinet. It oxidises in water, browns in light, and loses activity across a shelf life that a brand has to guarantee for years.
That single problem explains most of what a modern ingredient list looks like. When a pack says vitamin C, the material inside is frequently a derivative rather than ascorbic acid itself.
The derivative trade
3-O-ethyl ascorbic acid is the one that turns up most often in Korean-manufactured formulas. It is stable across a wider pH range, tolerates water without collapsing, and converts to ascorbic acid on the skin. The trade is potency: a derivative that survives the bottle delivers less active than the same percentage of the pure material would if the pure material had survived.
Other derivatives make different bargains — some are oil-soluble and suit anhydrous systems, others are more stable still and correspondingly slower. Brands hitting that wall increasingly ask about ingestible routes instead. There is no free option. A brief that asks for high-strength vitamin C, a clear formula that stays clear, and a three-year shelf life is asking for two of the three.
Pure ascorbic acid formulas are still made, and Rodial’s Vit C Brightening Serum is one of the visible examples of a brand building around a specific vitamin C choice. Going that route means accepting a low pH, tight packaging constraints, and a colour shift over time that customer service has to be briefed to explain rather than treat as a defect.
The rest of the active list, sorted by what it actually does
Pigmentation is not one mechanism, and the ingredients in a typical brightening serum are attacking different steps. Sorting them by mechanism makes the formula easier to defend and easier to write copy for.
- Niacinamide — interferes with pigment transfer to the surface cells rather than with pigment production. It also supports barrier function, which is why it appears in almost every formula in the category regardless of what else is in there.
- Tranexamic acid — works further upstream, on the signalling that drives melanin production. It has become the ingredient buyers ask for by name.
- Alpha-arbutin — a tyrosinase inhibitor, and the material that filled the gap left by hydroquinone, which is prohibited in cosmetics in the EU and is not sold over the counter in the United States.
- Glutathione — an antioxidant with a strong consumer story in several Asian markets and a topical delivery question that is worth being honest about internally.
- PHA — gentler exfoliation than the traditional alpha hydroxy acids, larger molecule, slower penetration. It opens the category to skin that cannot tolerate glycolic acid.
Madecassoside and PDRN show up on the soothing and recovery side rather than the pigment side. They are there because the pigment actives are irritants, and an irritated barrier produces more pigment, not less — which makes the calming half of the formula functional rather than decorative.
Packaging is part of the formulation, not a decision made after it
Light and oxygen are the two things that degrade this category, so the container is doing real chemical work. Airless pumps, opaque or tinted glass, and small fill volumes all extend usable life. Clear droppers look premium in a flat lay and expose the contents to both problems every time the bottle is opened.
Fill size deserves more thought than it usually gets. A 30ml bottle of an unstable formula that a consumer uses over four months has spent most of that time degrading. A 15ml fill at a lower price point can be the better product decision even though it looks like a worse value proposition on the shelf.
This is also where a lot of cost sits. Airless components are more expensive than droppers, and the difference has to be built into the target price at the brief stage rather than discovered when the first quote comes back.
What you’re allowed to say depends on where you ship
Claim language is the part of this category that most often derails a launch timeline, because brightening sits close to a regulated boundary in several markets.
Korea treats whitening as a functional cosmetic category under the Ministry of Food and Drug Safety, which means the claim comes with a defined route rather than being free text on a pack. Other markets restrict how far a cosmetic can go toward describing a change in pigmentation before the product is treated as something other than a cosmetic. The workable wording is usually about the appearance of dark spots and evenness of tone, and it has to be checked against the destination before the packaging artwork is signed off.
The same caution applies to before-and-after imagery. Photographs supporting a claim need to be produced under conditions the brand can describe if asked — lighting, distance, timing — and a set shot casually during development rarely survives that question later.
Timelines matter here too. Pigmentation responds slowly, and a launch campaign promising results in a fortnight sets up a return and review problem at exactly the point where the product would have started to show something. Setting expectations at a realistic horizon in the copy is a commercial decision with a measurable effect on repeat purchase.
“Brightening is still one of the most requested categories from brands sourcing skincare, but the bar has moved. Buyers no longer see a single serum as differentiated on its own — what we hear now is demand for brightening positioned as a routine, with a mask or a treatment step alongside it, because that gives the brand more shelf presence and a repeat-purchase story. The other shift is on claims: brands arriving with their target market and their claim wording already checked get through development considerably faster than ones who assume the copy can be finalised at the end.” — Hyejin Cho, Digital Marketing Specialist, Marketing and Communication Team at SPSCOS
Routine positioning beats hero positioning
The commercial argument for building around a routine rather than a single hero product is straightforward. A serum alone gives a brand one purchase occasion and one content angle. A serum with a companion step — a mask pack used twice a week, or a targeted eye product for the area where pigmentation shows first — gives a brand two price points, a sequencing story, and a reason for the customer to come back on a shorter cycle.
It also solves a formulation problem. Actives that fight each other in one bottle can be separated across two steps, which is often the cleaner answer to a brief asking for six ingredients that don’t want to share a pH.
For brands where the visible outcome matters more than the mechanism, pairing the serum with a hydration-led step does more for how the skin looks in the first weeks than adding another pigment active would. Hydrated skin reflects light more evenly, and a lot of what consumers describe as radiance is that, not depigmentation.
The brief that works
Name the market first, because it decides the claim language and the claim language decides the formula. Pick the vitamin C form deliberately and accept its trade rather than asking for a material that doesn’t exist. Set the packaging spec alongside the formula, not after it. And decide whether this is one product or the anchor of a routine before the first sample, because the two projects have different active lists, different price points, and different launch plans.